Skip to main content

Table 1 Clinical characteristics of stage III colon cancer patients by hospital length of stay cohorts

From: Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon cancer

Variables

Length of stay (days)

p-value

Total (n = 690)

≤ 5 (n = 202)

6–8 (n = 248)

> 8 (n = 240)

Length of stay (days)

 Median (min-max)

5 (3–5)

7 (6–8)

12 (9–51)

 

7 (3–51)

 Mean

4.5

6.9

14.5

 

8.8

Age, median (min-max)

69 (27–92)

69 (19–91)

73 (19–93)

< 0.05

71 (19–93)

Gender,n(%)

 Female

106 (52)

145 (58)

124 (52)

NS

375 (54)

 Male

96 (48)

103 (42)

116 (48)

 

315 (46)

Surgery,n(%)a

 Open

142 (70)

221 (89)

222 (93)

< 0.01

585 (85)

 Laparoscopic

60 (30)

27 (11)

18 (8)

 

105 (15)

Tumor location,n(%)a

 Right sided

113 (56)

134 (54)

121 (50)

NS

368 (53)

 Left sided

88 (44)

113 (46)

112 (47)

 

313 (45)

 Multiple locations

1 (1)

1 (0)

7 (3)

 

9 (1)

Differentiation grade,n(%)a

 Low grade (G1–G2)

142 (70)

172 (69)

169 (70)

NS

483 (70)

 High grade (G3–G4)

47 (23)

63 (25)

58 (24)

 

168 (24)

 Mucinous

13 (6)

13 (5)

13 (5)

 

39 (6)

T-stage,n(%)a

 1

5 (2)

2 (1)

3 (1)

NS

10 (1)

 2

14 (7)

16 (6)

14 (6)

 

44 (6)

 3

150 (74)

178 (72)

159 (66)

 

487 (71)

 4

33 (16)

52 (21)

64 (27)

 

149 (22)

N-stage,n(%)

 N1

136 (67)

152 (61)

158 (66)

NS

446 (65)

 N2

66 (33)

96 (39)

82 (34)

 

244 (35)

Adjuvant chemotherapy,n(%)

 Yes

140 (69)

169 (68)

125 (52)

< 0.01

434 (63)

 No

62 (31)

79 (32)

115 (48)

 

256 (37)

Timing of adjuvant chemotherapy,n(%)

 < 8 weeks

59 (42)

72 (43)

36 (29)

< 0.05

167 (38)

 > 8 weeks

81 (58)

97 (57)

89 (71)

 

267 (62)

ACCI,n(%)

 0–2

89 (44)

104 (42)

69 (29)

< 0.01

262 (38)

 3–5

107 (53)

127 (51)

142 (59)

 

376 (54)

 6–9

6 (3)

17 (7)

29 (12)

 

52 (8)

Clavien-Dindo,n(%)

 0–3a

202 (100)

239 (96)

203 (85)

< 0.01

644 (93)

 3b–4

–

9 (4)

37 (15)

 

46 (7)

Readmissionb,n(%)

 No

189 (94)

229 (92)

225 (94)

NS

643 (93)

 Yes

13 (6)

19 (8)

15 (6)

 

47 (7)

  1. Percentages within the parentheses should be read vertically, representing the top subject
  2. Abbreviations: IQR interquartile range, ACCI age-adjusted Charlson Comorbidity Index, NS not significant.
  3. aPercentage does not add up due to rounding
  4. bWithin 30 days
Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us